KIORA PHARMACEUTICALS INC (KPRX)
US49721T3095 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.51M | -13.58M | -13.77M | -8.09M | -7.10M | |||
| Depreciation Amortization | 51.80K | 40.00K | 50.00K | 30.00K | 50.00K | |||
| Income Taxes - Deferred | 90.32K | -110.00K | -190.00K | 10.00K | 100.00K | |||
| Change In Working Capital | -1.82M | 670.00K | -1.04M | -320.00K | -2.72M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 4.64M | 2.56M | 4.28M | 1.05M | 1.51M | |||
| OPERATING CASH FLOW | -9.56M | -10.43M | -10.68M | -7.32M | -8.15M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -60.00K | -20.00K | 0.00 | |||
| Other Investing Activity | 0.00 | 10.00K | -90.00K | -220.00K | N/A | |||
| INVESTING CASH FLOW | 0.00 | 10.00K | -160.00K | -240.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -210.00K | 280.00K | 0.00 | |||
| Stock Issued/Repurchased | 6.02M | 8.64M | 18.80M | 5.22M | 3.93M | |||
| Other Financing Activity | -52.69K | -20.00K | -1.00M | -500.00K | 0.00 | |||
| FINANCING CASH FLOW | 5.97M | 8.62M | 17.58M | 5.00M | 3.92M | |||
| Exchange Rate Effect | 36.02K | -90.00K | -80.00K | -30.00K | 10.00K | |||
| CHANGE IN CASH | -3.55M | -1.89M | 6.66M | -2.59M | -4.22M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.56M | -10.43M | -10.68M | -7.32M | -8.15M | |||
| Capital Expenditure | N/A | 0.00 | -60.00K | -20.00K | 0.00 | |||
| FREE CASH FLOW | -9.56M | -10.43M | -10.74M | -7.34M | -8.15M | |||
All data in USD